ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary

@article{Pavel2011ENETSCG,
  title={ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary},
  author={Marianne Ellen Pavel and Eric Baudin and Anne Couvelard and Eric Paul Krenning and Kjell E. {\"O}berg and Th. Steinm{\"u}ller and Martin Anlauf and Bertram Wiedenmann and Ramon Salazar},
  journal={Neuroendocrinology},
  year={2011},
  volume={95},
  pages={157 - 176}
}
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary 

Figures and Tables from this paper

ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site
TLDR
The goal of this paper is to update a more extensive review and guidelines paper published in 2012 with any pertinent update pertaining to the diagnosis and staging of individual prima prima cancer patients.
ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors
ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System : Well-Differentiated Pancreatic Non-Functioning Tumors
ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Colorectal Neuroendocrine Neoplasms
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms : colorectal neuroendocrine neoplasms
ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
TLDR
The ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatics with Functional and non-functional tumours is published.
Resection Versus Chemotherapy for Metastatic Neuroendocrine Tumors of the Pancreas
TLDR
This chapter focuses on the debate between surgery and chemotherapy for metastatic PNET, and summarizes the evidence for both strategies including which treatment is appropriate in each clinical setting.
Tumor Staging: Pancreas
In patients with pancreatic neuroendocrine tumors (pNETs), the assessment of the tumor extent and location and the evaluation of any possible local and/or distant metastases are both required to
Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021
TLDR
Clinical practice guidelines for the management of metastatic liver tumors are created by the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery.
Neuroendocrine liver metastasis: The chance to be cured after liver surgery
TLDR
This work aimed to identify the fraction of patients cured after liver surgery for NELM, a heterogeneous group of neoplasms with varied histologic features and a wide range of clinical behaviors.
Erratum to: Surgical therapy of neuroendocrine neoplasm with hepatic metastasis: patient selection and prognosis
TLDR
The aims of this study were to evaluate the outcome/prognosis of patients following hepatic surgery and to identify predictive factors for the selection of patient that benefit from hepatic tumor resection.
Management and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: An international multi‐institutional analysis
We sought to characterize the treatment, as well as define the long‐term outcomes, of patients with recurrent neuroendocrine liver metastasis (NELM).
...
...

References

SHOWING 1-10 OF 194 REFERENCES
Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors – Well-Differentiated Jejunal-Ileal Tumor/Carcinoma
Consensus guidelines for the management of patients with digestive neuroendocrine tumors : well-differentiated jejunal-ileal tumor/carcinoma
ENETS Consensus Guidelines for the Management of Brain, Cardiac and Ovarian Metastases from Neuroendocrine Tumors
TLDR
ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumors and their implications for clinical practice are published.
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a Standardized Approach to the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors and Their Prognostic Stratification
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors : towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic
ENETS Consensus Guidelines for the Management of Bone and Lung Metastases from Neuroendocrine Tumors
TLDR
ENETS consensus guidelines for the management of bone and lung metastases from neuroendocrine tumors and their implications for clinical practice are published.
ENETS Consensus Guidelines for the Management of Peritoneal Carcinomatosis from Neuroendocrine Tumors
ENETS Consensus Guidelines for the Management of Peritoneal Carcinomatosis from Neuroendocrine Tumors
Consensus Guidelines for the Management of Patients with Liver Metastases from Digestive (Neuro)endocrine Tumors: Foregut, Midgut, Hindgut, and Unknown Primary
TLDR
This poster presents a poster presented at the 2016 European Congress of Nuclear Medicine, entitled “Advances in Nuclear Medicine and Pathology: Foundations of Surgeons’ Ethics and Practice, 2nd Ed.” in Amsterdam.
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological Examinations
TLDR
The ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors : Radiological Examinations show clear trends in acceptable levels of care for these patients and provide a roadmap for future generations to follow.
Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors
Neuroendocrine tumors (NETs) of the gastroenteropancreatic (GEP) system comprise a rare but challenging group of malignant neoplasms and occur at virtually any site of the GEP system. In 2006, a new
Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors a prospective phase II study in 24 patients
TLDR
Locoregional treatment has allowed transient control of hepatic tumor growth and is of major prognostic significance in liver metastases of endocrine tumors.
Liver Transplantation for Treatment of Metastatic Neuroendocrine Tumors
Abstract: Liver transplantation can be considered a therapeutic option for patients with neuroendocrine tumors only metastatic to the liver. Important selection criteria are well‐differentiated
...
...